NCT06029712 - Heart Failure Polypill at a Safety Net Hospital | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

September 17, 2024

Study Completion Date

January 29, 2025

Conditions

Heart Failure With Reduced Ejection FractionHIV Infections

Interventions

DRUG

Heart failure polypill

Copackaging of heart failure medications (beta blocker, SGLT2i, MRA, and ACE/ARB/ARNI) in an overencapsulated polypill. Individual tablets will be hand-packed into a single capsule at the level of the pharmacy. Specific medications and doses will be individualized to the participant.

DRUG

Control Rx

GDMT delivered as individual tablets

Trial Locations (1)

94110

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER